Welcome to Pangaea insights
Our collective intelligence provides an unrivalled breadth and depth of knowledge.
Pangaea’s ongoing relationships with key industry stakeholders facilitate continuous updates and dissemination of relevant market intelligence. Check back often for new posts!
Measuring MSL Value: Metrics that Matter
July 25, 2017
Medical Science Liaisons (MSLs) have been around for about 50 years. Upjohn Pharmaceuticals first created this unique position in 1967, aimed at building relationships and research collaborations with Key Opinion Leaders (KOLs).
MSL Benchmarking in Canada: Pangaea Study Now Underway and Results Available September 2017
May 25, 2017
Pangaea is currently assisting Biotech and Pharmaceutical clients to benchmark MSL Activity in Canada through their participation in a MSL Benchmarking study.
Pangaea Express: McKesson Canada offers to acquire Groupe Uniprix
May 22, 2017
McKesson Canada presented their acquisition offer during a special assembly with the pharmacists/ shareholders of Uniprix in early May. 2017.
Pangaea Express: OHIP+: Children and Youth Pharmacare
May 19, 2017
As part of the 2018 budget unveiled last Thursday, Ontario announced it’s new "OHIP+: Children and Youth Pharmacare" plan, a publicly funded drug coverage program for youth up to the age of 24.
Pangaea Express: Professional Fees and Professional Allowance in Quebec
May 15, 2017
The legal dispute between the Health Minister and the AQPP has found a resolution with a new agreement.
Canada 101: Biopharmaceutical opportunities
May 5, 2017
To be held Wednesday May 24th at the Canadian Consulate in Boston.
Pangaea Express: Health Canada proposes Public Release of Clinical Information in Drug Submissions and Medical Device Applications
April 17, 2017
Health Canada has released a white paper outlining its proposed initiative to make specified clinical information from drug submissions and medical device applications publicly available following the completion of its regulatory review process.
The Biosimilar: Branded or Generic? Interchangeable or Not?
March 15, 2017
Depending on how one approaches the questions posed by this article’s title, the answers are either crystal clear or clear as mud. And here’s why.
Pangaea Express: McKesson aquisition of GMD
February 6, 2017
McKesson Canada announced its intent to acquire GMD PharmaSolutions (GMD), enhancing their specialty health services to patients, providers, payers and manufacturers.
Pangaea Express: Health Canada Submission Requirements for Biosimilar Biologic Drugs
December 23, 2016
Health Canada has released its revised guidelines for submission requirements for biosimilar biologic drugs. The “Guidance Document Information and Submission Requirements for Biosimilar Biologic Drugs” was posted online December 2nd 2016.